Eikon Therapeutics, Inc. Common Stock (EIKN) — Financial Flexibility Index
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-41.66 Million (operating CF $-41.72 Million minus capex $66.00K) represents 0% of total liabilities ($1.47 Billion). Also explore Eikon Therapeutics, Inc. Common Stock (EIKN) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eikon Therapeutics, Inc. Common Stock Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Eikon Therapeutics, Inc. Common Stock across 3 annual periods. Check EIKN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Eikon Therapeutics, Inc. Common Stock (2023–2025)
Year-by-year free cash flow to debt coverage for Eikon Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Eikon Therapeutics, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-141.78 Million | $-188.52 Million | $1.47 Billion | ▼ -104.6% |
| 2024 | -0.05x | $-50.00 Million | $-134.80 Million | $1.06 Billion | ▲ +74.9% |
| 2023 | -0.19x | $-162.34 Million | $-190.85 Million | $867.08 Million | — |